PT - JOURNAL ARTICLE AU - Dudding, T. AU - Sheikh, S. AU - Gregson, F. AU - Haworth, J. AU - Haworth, S. AU - Main, B.G. AU - Shrimpton, A.J. AU - Hamilton, F.W. AU - , AU - Ireland, A.J. AU - Maskell, N.A. AU - Reid, J.P. AU - Bzdek, B.R. AU - Gormley, M. TI - A clinical observational analysis of aerosol emissions from dental procedures AID - 10.1101/2021.06.09.21258479 DP - 2021 Jan 01 TA - medRxiv PG - 2021.06.09.21258479 4099 - http://medrxiv.org/content/early/2021/10/19/2021.06.09.21258479.short 4100 - http://medrxiv.org/content/early/2021/10/19/2021.06.09.21258479.full AB - Aerosol generating procedures (AGPs) are defined as any procedure releasing airborne particles <5 μm in size from the respiratory tract. There remains uncertainty about which dental procedures constitute AGPs. We quantified the aerosol concentration generated during a range of periodontal, oral surgery and orthodontic procedures using an aerodynamic particle sizer, which measures the total concentration and size distribution across the 0.5–20 μm diameter size range. Measurements were conducted in an environment with a sufficiently low background to detect a patient’s cough, enabling confident identification of aerosol. Phantom head control experiments for each procedure were performed under the same conditions as a comparison. Where aerosol was detected during a patient procedure, we assessed whether the size distribution could be explained by the non-salivary contaminated instrument source in the respective phantom head control procedure, using a two-sided unpaired t-test (comparing the mode widths (log(σ)) and peak positions (DP,C)). The aerosol size distribution provided a robust fingerprint, describing aerosol emission from a source. 41 patients underwent fifteen different dental procedures. For nine of these, no aerosol was detected above background. Where aerosol was detected, the percentage of procedure time that aerosol was observed above background ranged from 12.7% for ultrasonic scaling, to 42.9% for 3-in-1 air + water syringe. For ultrasonic scaling, 3-in-1 syringe use and surgical drilling, the aerosol size distribution matched the non-salivary contaminated instrument source, with no unexplained aerosol. High and slow speed drilling produced aerosol from patient procedures with different size distributions to those measured from the phantom head controls (mode widths log(σ)) and peaks (DP,C) p< 0.002) and therefore, may pose a greater risk of salivary contamination. This study provides evidence for sources of aerosol generation during common dental procedures, enabling more informed evaluation of risk and appropriate mitigation strategies.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe AERosolisation And Transmission Of SARS-CoV-2 in Healthcare Settings (AERATOR) study was funded by National Institute of Health Research (NIHR) (Award ID: COV0333) and has been awarded urgent public health status (IRAS-Number: 288784; CPMS-ID: 47097). T. Dudding is supported by NIHR through the Academic Clinical Fellowship scheme. M. Gormley is supported by a Wellcome Trust GW4-Clinical Academic Training PhD Fellowship. This research was funded in part, by the Wellcome Trust [Grant number 220530/Z/20/Z]. For the purpose of open access, the author has applied a CC BY public copyright licence to any Author Accepted Manuscript version arising from this submission. Bryan R. Bzdek is supported by the Natural Environment Research Council (NE/P018459/1). S. Haworth is supported by NIHR through the Academic Clinical Fellowship scheme.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:North West Research Ethics Committee (Ref: 20/NW/0393, HRA Approved 18/09/2020)I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesSummary level aerosol distribution data can be requested from the authors.